BIOMAT Database Logo BIOMAT Database Logo

Evaluation of psoralen-UV-B (311-nm) bath phototoxicity. 1998

N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann

UI MeSH Term Description Entries
D008297 Male Males
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D005260 Female Females
D005363 Ficusin A naturally occurring furocoumarin, found in PSORALEA. After photoactivation with UV radiation, it binds DNA via single and double-stranded cross-linking. Psoralen,Psoralene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing

Related Publications

N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Phototoxicity of narrowband ultraviolet (UV) B (311 nm) compared with broadband UVB in the photo hen's egg test.
February 2015, The British journal of dermatology,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Concentration-dependent phototoxicity in trimethylpsoralen bath psoralen ultraviolet A.
March 2001, The British journal of dermatology,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Evaluation of PUVA bath phototoxicity.
September 1997, Acta dermato-venereologica,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
October 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Kinetics of phototoxicity in trioxysalen bath psoralen plus ultraviolet A photochemotherapy.
January 2001, Acta dermato-venereologica,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm).
January 2005, Pediatric dermatology,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Psoralen bath plus UV-A therapy. Possibilities and limitations.
December 1997, Archives of dermatology,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Bath psoralen-UV-A therapy for persistent Grover disease.
May 1999, Archives of dermatology,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
February 2007, Photodermatology, photoimmunology & photomedicine,
N J Neumann, and K Schlotmann, and T Ruzicka, and P Lehmann
[Therapeutic effectiveness of psoralen-UV-A bath therapy in psoriasis].
April 2009, Actas dermo-sifiliograficas,
Copied contents to your clipboard!